FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060897125> ?p ?o ?g. }

• W2060897125 endingPage "88" @default.
• W2060897125 startingPage "77" @default.
• W2060897125 abstract "Fluorescence polarization (FP) has been used to develop high throughput screening (HTS) assays for nuclear receptor-ligand displacement and kinase inhibition. FP is a solution-based, homogeneous technique requiring no immobilization or separation of reaction components. The FP-based estrogen receptor (ER) assay is based on the competition of fluorescein-labeled estradiol and estrogen-like compounds for binding to ER. These studies determined the Kd for this interaction to be 3 nM for ERalpha and 2 nM for ERbeta; IC50 values for 17beta-estradiol, tamoxifen, 4-OH-tamoxifen, and diethylstibestrol were determined to be 5.6, 189, 26, and 3.5 nM, respectively. In a screen of 50 lead compounds from a transcriptional activation screen, 21 compounds had IC50 values below 10 microM, with one having an almost 100-fold higher affinity for ERbeta over ERalpha. These data show that an FP-based competitive binding assay can be used to screen diverse compounds with a broad range of binding affinities for ERs. The FP-based protein-tyrosine kinase (PTK) assay uses fluorescein-labeled phosphopeptides bound to anti-phosphotyrosine antibodies. Phosphopeptides generated by a kinase compete for this binding. In c-Src kinase reactions, polarization decreased with time as reaction products displaced the fluorescein-labeled phosphopeptide from the anti-phosphotyrosine antibodies. The experimentally determined IC50 of AG 1478 was 400 pM, while Genistein did not inhibit the epidermal growth factor receptor at similar concentrations. Like the FP-based PTK assay, the protein kinase C (PKC) assay utilizes competition. PKC isoforms had different turnover rates for the peptide substrate. The IC50 for staurosporine was less than 10 nM for all PKC isoforms. Tyrosine phosphatase assays use direct binding rather than competition. Increasing concentrations of T-cell protein-tyrosine phosphatase (TC PTP) increased the rate of dephosphorylation. This change in polarization was dependent on TC PTP and was inhibited by 50 microM Na3VO4. The IC50 of Na3VO4 was 4 nM for TC PTP. These data demonstrate that a FP-based assay can detect kinase and phosphatase activity. Homogeneous, fluorescent techniques such as FP are now methods of choice for screening many types of drug targets. New HTS instrumentation and assay methods like these make FP a technology easily incorporated into HTS." @default.
• W2060897125 created "2016-06-24" @default.
• W2060897125 creator A5073576369 @default.
• W2060897125 creator A5076067873 @default.
• W2060897125 creator A5083769787 @default.
• W2060897125 creator A5087494697 @default.
• W2060897125 date "2000-04-01" @default.
• W2060897125 modified "2023-10-15" @default.
• W2060897125 title "Development of High Throughput Screening Assays Using Fluorescence Polarization: Nuclear Receptor-Ligand–Binding and Kinase /Phosphatase Assays" @default.
• W2060897125 cites W1516538526 @default.
• W2060897125 cites W1522655814 @default.
• W2060897125 cites W1554955915 @default.
• W2060897125 cites W1589866689 @default.
• W2060897125 cites W1964504843 @default.
• W2060897125 cites W1964839077 @default.
• W2060897125 cites W1970174108 @default.
• W2060897125 cites W1982186905 @default.
• W2060897125 cites W1988772167 @default.
• W2060897125 cites W1991972636 @default.
• W2060897125 cites W2026408020 @default.
• W2060897125 cites W2026799822 @default.
• W2060897125 cites W2031415145 @default.
• W2060897125 cites W2041859669 @default.
• W2060897125 cites W2042124938 @default.
• W2060897125 cites W2051478356 @default.
• W2060897125 cites W2054822444 @default.
• W2060897125 cites W2056550656 @default.
• W2060897125 cites W2073353512 @default.
• W2060897125 cites W2083912020 @default.
• W2060897125 cites W2086524338 @default.
• W2060897125 cites W2089486914 @default.
• W2060897125 cites W2092520899 @default.
• W2060897125 cites W2097558464 @default.
• W2060897125 cites W2124307177 @default.
• W2060897125 cites W2163362369 @default.
• W2060897125 cites W2166708153 @default.
• W2060897125 doi "https://doi.org/10.1177/108705710000500204" @default.
• W2060897125 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10803607" @default.
• W2060897125 hasPublicationYear "2000" @default.
• W2060897125 type Work @default.
• W2060897125 sameAs 2060897125 @default.
• W2060897125 citedByCount "200" @default.
• W2060897125 countsByYear W20608971252012 @default.
• W2060897125 countsByYear W20608971252013 @default.
• W2060897125 countsByYear W20608971252014 @default.
• W2060897125 countsByYear W20608971252015 @default.
• W2060897125 countsByYear W20608971252016 @default.
• W2060897125 countsByYear W20608971252017 @default.
• W2060897125 countsByYear W20608971252018 @default.
• W2060897125 countsByYear W20608971252019 @default.
• W2060897125 countsByYear W20608971252020 @default.
• W2060897125 countsByYear W20608971252022 @default.
• W2060897125 countsByYear W20608971252023 @default.
• W2060897125 crossrefType "journal-article" @default.
• W2060897125 hasAuthorship W2060897125A5073576369 @default.
• W2060897125 hasAuthorship W2060897125A5076067873 @default.
• W2060897125 hasAuthorship W2060897125A5083769787 @default.
• W2060897125 hasAuthorship W2060897125A5087494697 @default.
• W2060897125 hasBestOaLocation W20608971251 @default.
• W2060897125 hasConcept C111357860 @default.
• W2060897125 hasConcept C121608353 @default.
• W2060897125 hasConcept C153911025 @default.
• W2060897125 hasConcept C170493617 @default.
• W2060897125 hasConcept C184235292 @default.
• W2060897125 hasConcept C185592680 @default.
• W2060897125 hasConcept C195794163 @default.
• W2060897125 hasConcept C202751555 @default.
• W2060897125 hasConcept C2777752497 @default.
• W2060897125 hasConcept C41625074 @default.
• W2060897125 hasConcept C42362537 @default.
• W2060897125 hasConcept C530470458 @default.
• W2060897125 hasConcept C54355233 @default.
• W2060897125 hasConcept C55493867 @default.
• W2060897125 hasConcept C84606932 @default.
• W2060897125 hasConcept C85196483 @default.
• W2060897125 hasConcept C86803240 @default.
• W2060897125 hasConcept C97029542 @default.
• W2060897125 hasConceptScore W2060897125C111357860 @default.
• W2060897125 hasConceptScore W2060897125C121608353 @default.
• W2060897125 hasConceptScore W2060897125C153911025 @default.
• W2060897125 hasConceptScore W2060897125C170493617 @default.
• W2060897125 hasConceptScore W2060897125C184235292 @default.
• W2060897125 hasConceptScore W2060897125C185592680 @default.
• W2060897125 hasConceptScore W2060897125C195794163 @default.
• W2060897125 hasConceptScore W2060897125C202751555 @default.
• W2060897125 hasConceptScore W2060897125C2777752497 @default.
• W2060897125 hasConceptScore W2060897125C41625074 @default.
• W2060897125 hasConceptScore W2060897125C42362537 @default.
• W2060897125 hasConceptScore W2060897125C530470458 @default.
• W2060897125 hasConceptScore W2060897125C54355233 @default.
• W2060897125 hasConceptScore W2060897125C55493867 @default.
• W2060897125 hasConceptScore W2060897125C84606932 @default.
• W2060897125 hasConceptScore W2060897125C85196483 @default.
• W2060897125 hasConceptScore W2060897125C86803240 @default.
• W2060897125 hasConceptScore W2060897125C97029542 @default.
• W2060897125 hasIssue "2" @default.
• W2060897125 hasLocation W20608971251 @default.
• W2060897125 hasLocation W20608971252 @default.

• next